SCOTT RUNYON, M.D.
Anesthesiologist Assistant at Erwin Rd, Durham, NC
License number
North Carolina 157133
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
2100 Erwin Rd, Durham, NC 27705
Phone
(919) 684-8111
Professional information
Senior Scientist At Rti International
Position:
Senior Scientist at RTI International
Location:
Raleigh-Durham, North Carolina Area
Industry:
Research
Work:
RTI International
- RTP, NC since Sep 2001
-
Senior Scientist
US Ink
Jan 1994 - Aug 1995
-
chemist
Education:
Virginia Commonwealth University 1995 - 2001
Ph.D., Medicinal Chemistry Muhlenberg College 1990 - 1994
B.S., Chemistry
Ph.D., Medicinal Chemistry Muhlenberg College 1990 - 1994
B.S., Chemistry
Dr. Scott Runyon, Durham NC - MD (Doctor of Medicine)
Specialties:
Pain Medicine
Age:
45
Address:
2301 Erwin Rd, Durham 27705
2100 Erwin Rd, Durham 27705
(919) 684-8111 (Phone)
Durham Office
2301 Erwin Rd, Durham 27705
(919) 668-4000 (Phone)
Durham Office
2301 Erwin Rd STE 6TH, Durham 27705
(919) 668-4111 (Phone)
932 Morreene Rd, Durham 27705
(919) 668-7600 (Phone), (919) 613-4525 (Fax)
101 Manning Dr, Chapel Hill 27514
(919) 843-6688 (Phone), (919) 843-9313 (Fax)
2100 Erwin Rd, Durham 27705
(919) 684-8111 (Phone)
Durham Office
2301 Erwin Rd, Durham 27705
(919) 668-4000 (Phone)
Durham Office
2301 Erwin Rd STE 6TH, Durham 27705
(919) 668-4111 (Phone)
932 Morreene Rd, Durham 27705
(919) 668-7600 (Phone), (919) 613-4525 (Fax)
101 Manning Dr, Chapel Hill 27514
(919) 843-6688 (Phone), (919) 843-9313 (Fax)
Languages:
English
Hospitals:
2301 Erwin Rd, Durham 27705
2100 Erwin Rd, Durham 27705
932 Morreene Rd, Durham 27705
101 Manning Dr, Chapel Hill 27514
Durham Office
2301 Erwin Rd, Durham 27705
Durham Office
2301 Erwin Rd STE 6TH, Durham 27705
Milton S. Hershey Medical Center
500 University Dr, Hershey 17033
2100 Erwin Rd, Durham 27705
932 Morreene Rd, Durham 27705
101 Manning Dr, Chapel Hill 27514
Durham Office
2301 Erwin Rd, Durham 27705
Durham Office
2301 Erwin Rd STE 6TH, Durham 27705
Milton S. Hershey Medical Center
500 University Dr, Hershey 17033
Education:
Medical School
Pennsylvania State University / College of Medicine
Graduated: 2008
Pennsylvania State University / College of Medicine
Graduated: 2008
Kappa Opioid Receptor Ligands
US Patent:
2006018, Aug 17, 2006
Filed:
Feb 17, 2005
Appl. No.:
11/059390
Inventors:
Carroll Frank - Research Triangle Park NC, US
Hernan Navarro - Research Triangle Park NC, US
Lawrence Brieaddy - Research Triangle Park NC, US
Scott Runyon - Research Triangle Park NC, US
Hernan Navarro - Research Triangle Park NC, US
Lawrence Brieaddy - Research Triangle Park NC, US
Scott Runyon - Research Triangle Park NC, US
Assignee:
Research Triangle Institute - Research Triangle Park NC
International Classification:
A61K 31/53, A61K 31/506, A61K 31/4545, A61K 31/445
US Classification:
514241000, 514256000, 514317000, 514318000
Abstract:
Kappa opioid receptor antagonists are provided that yield significant improvements in functional binding assays to kappa opioid receptors, and the use of these antagonists in treatment of disease states that are ameliorated by binding of the kappa opioid receptor such as heroin or cocaine addictions.
Kappa Opioid Receptor Ligands
US Patent:
2012017, Jul 12, 2012
Filed:
Feb 29, 2012
Appl. No.:
13/408309
Inventors:
Frank Ivy CARROLL - Research Triangle Park NC, US
Hernan A. Navarro - Research Triangle Park NC, US
Lawrence E. Brieaddy - Research Triangle Park NC, US
Scott P. Runyon - Research Triangle Park NC, US
James B. Thomas - Efland NC, US
Hernan A. Navarro - Research Triangle Park NC, US
Lawrence E. Brieaddy - Research Triangle Park NC, US
Scott P. Runyon - Research Triangle Park NC, US
James B. Thomas - Efland NC, US
Assignee:
RESEARCH TRIANGLE INSTITUTE - Research Triangle Park NC
International Classification:
A61K 31/4535, A61K 31/453, A61P 25/06, A61P 37/02, A61P 37/06, A61P 19/02, A61P 37/08, A61P 31/12, A61P 1/12, A61P 25/18, A61P 25/24, A61P 11/14, A61P 25/30, A61P 9/12, A61P 3/04, A61P 25/08, C07D 211/08
US Classification:
514324, 546196, 514320, 546202
Abstract:
Kappa opioid receptor antagonists are provided that yield significant improvements in functional binding assays to kappa opioid receptors, and the use of these antagonists in treatment of disease states that are ameliorated by binding of the kappa opioid receptor such as heroin or cocaine addictions.
Kappa Opioid Receptor Ligands
US Patent:
8173678, May 8, 2012
Filed:
Oct 25, 2010
Appl. No.:
12/911244
Inventors:
Frank Ivy Carroll - Research Triangle Park NC, US
Hernan A. Navarro - Research Triangle Park NC, US
Lawrence E. Brieaddy - Research Triangle Park NC, US
Scott P. Runyon - Research Triangle Park NC, US
James B. Thomas - Efland NC, US
Hernan A. Navarro - Research Triangle Park NC, US
Lawrence E. Brieaddy - Research Triangle Park NC, US
Scott P. Runyon - Research Triangle Park NC, US
James B. Thomas - Efland NC, US
Assignee:
Research Triangle Institute - Research Triangle Park NC
International Classification:
A61K 31/451, A61K 31/453, C07D 227/06, C07D 471/18, C07D 211/18, C07D 401/12
US Classification:
514319, 514277, 514279, 514338, 514411, 546 74, 546240, 546196, 546 46, 546 35
Abstract:
Kappa opioid receptor antagonists are provided that yield significant improvements in functional binding assays to kappa opioid receptors, and the use of these antagonists in treatment of disease states that are ameliorated by binding of the kappa opioid receptor such as heroin or cocaine addictions.